The U.S. Environmental Protection Agency (EPA) announced on September 9 a study to test metropolitan water samples for various pollutants. Among the substances being tracked are mifepristone and misoprostol, the medications used for abortion.
The EPA's September 9 study on mifepristone and misoprostol
The Environmental Protection Agency (EPA) is utilizing a "non-targeted analysis" to scan water samples across several unspecified metropolitan areas. According to the report, this method allows scientists to identify a wide array of substances simultaneously, though it only determines if a chemical is present rather than measuring its specific concentration. In addition to abortion medications, the EPA is searching for testosterone, progesterone, and levonorgestrel, a component found in many hormonal IUDs and emergency contraceptives like Plan B.
This move comes as the anti-abortion movement seeks new ways to restrict access to medication abortion, which has surged via telehealth since the end of constitutional abortion rights. Anna Bernstein, a federal policy adviser at the Guttmacher Institute, suggests that these efforts are an attempt to "weaponize laws" originally designed to protect the environment and wastewater systems.
Why <1% of the population using mifepristone makes water contamination unlikely
From a scientific standpoint,the idea that abortion pills are poisoning the water suply lacks evidence. Nathan Donley, director of environmental science at the Center for Biological Diversity, notes that less than one percent of the U.S. population has used mifepristone and misoprostol. Furthermore,these are typically one-time doses, unlike daily medications that enter wastewater systems in massive, constant volumes.
The biological reality of how the body processes medicine also contradicts the alarmist claims. thomas Young, a professor at the University of California Davis, explains that humans excrete most medicines rather than allowing them to accumulate in tissues. As reported in the source, a person would need to consume two liters of raw, untreated wastewater every day to be exposed to a single dose of these commonly prescribed medications.
How Students for Life is pushing the EPA to monitor abortion pills
The drive to include these drugs in federal water monitoring is largely linked to the advocacy of Students for Life. The group has previously petitioned the FDA to reverse the approval of mifepristone and published a study in a journal run by anti-abortion physicians claiming that these pills cause "chemically tainted" wastewater. However, environmental experts have dismissed that specific study as "misleading" and of "poor quality," arguing it should not influence public health policy.
The strategy appears to be a long-term regulatory play . By getting mifepristone onto a list of monitored contaminants, anti-abortion advocates can trigger a lengthy review process,potentially setting the stage for future water regulations that could be used to criminalize those who terminate their pregnancies.
The PFAS and Atrazine that actually pose a threat to U.S. water
While the EPA is focusing on abortion pills, experts argue that the agency is ignoring far more dangerous, well-documented pollutants. Nathan Donley points out that the EPA's list already includes PFAS, Atrazine (a widespread pesticide), Bifenthrin, Fipronil, and glyphosate. These chemicals have been known to contaminate U.S. water for decades, yet they lack the stringent regulations necessary to protect the public.
Donley suggests that the focus on medication abortion is a "delay tactic" used by the current administration to avoid implementing necessary regulations on industrial pollutants. By spending resources on a problem that does not exist, the government may be hamstringing its own ability to deal with the actual "chemical soup" found in American rivers and lakes.
Which unspecified metropolitan areas will the EPA actually test?
Despite the announcement, the EPA has not revealed which specific cities or metropolitan areas will be targeted for these water samples. This lack of transparency leaves several questions unanswered: will the agency target cities with high rates of telehealth abortion, and what specific threshold of detection will they use to claim a "presence" of these drugs? The source provides the perspective of environmental and policy experts but does not include a detailed rebuttal or specific methodology from the EPA officials overseeing the study.
Comments 0